B Bhoopathi, F Ostapowicz, W Bazley. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Acute DiseaseAdultAfibrinogenemia/complicationsBlood Cell CountBlood Coagulation Disorders/complicationsBlood TransfusionBone Marrow ExaminationCytarabine/administration & dosageCytarabine/therapeutic useEcchymosis/etiologyEstrogens, Conjugated (USP)/therapeutic useFactor V Deficiency/complicationsFemaleHumansLeukemia, Myeloid/complicationsLeukemia, Myeloid/drug therapyLeukocyte CountPregnancyPregnancy Complications, HematologicProthrombin TimeRemission, SpontaneousThioguanine/administration & dosageThioguanine/therapeutic useUterine Hemorrhage/drug therapyUterine Hemorrhage/etiology
Substances: See more » Estrogens, Conjugated (USP)CytarabineThioguanine
Year: 1973 PMID: 4346165
Source DB: PubMed Journal: Obstet Gynecol ISSN: 0029-7844 Impact factor: 7.661